Meletis, G.; Tychala, A.; Gkeka, I.; Gkotzia, A.; Triantafyllou, A.; Pappa, S.; Exindari, M.; Gioula, G.; Papa, A.; Skoura, L.
Clinical Performance Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay. Diagnostics 2022, 12, 3201.
https://doi.org/10.3390/diagnostics12123201
AMA Style
Meletis G, Tychala A, Gkeka I, Gkotzia A, Triantafyllou A, Pappa S, Exindari M, Gioula G, Papa A, Skoura L.
Clinical Performance Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay. Diagnostics. 2022; 12(12):3201.
https://doi.org/10.3390/diagnostics12123201
Chicago/Turabian Style
Meletis, Georgios, Areti Tychala, Ioanna Gkeka, Athanasia Gkotzia, Aikaterini Triantafyllou, Styliani Pappa, Maria Exindari, Georgia Gioula, Anna Papa, and Lemonia Skoura.
2022. "Clinical Performance Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay" Diagnostics 12, no. 12: 3201.
https://doi.org/10.3390/diagnostics12123201
APA Style
Meletis, G., Tychala, A., Gkeka, I., Gkotzia, A., Triantafyllou, A., Pappa, S., Exindari, M., Gioula, G., Papa, A., & Skoura, L.
(2022). Clinical Performance Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay. Diagnostics, 12(12), 3201.
https://doi.org/10.3390/diagnostics12123201